期刊
PHARMACEUTICAL RESEARCH
卷 29, 期 2, 页码 483-489出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-011-0571-x
关键词
benzalkonium chloride; cancer; delivery system; vaccine; gamma-polyglutamic acid
资金
- Uehara Memorial Foundation
- Global COE, Nagasaki University, Japan
- Japan Society for the Promotion of Science
To develop a novel cancer vaccine using the targeting system of antigen protein to antigen-presenting cells (APCs) for efficient and safe cancer therapy. The novel delivery system was constructed with antigen protein, benzalkonium chloride (BK), and gamma-polyglutamic acid (gamma-PGA), using ovalbumin (OVA) as a model antigen protein and evaluating its immune induction effects and utilities for cancer vaccine. BK and gamma-PGA enabled encapsulation of OVA and formed stable anionic particles at nanoscale, OVA/BK/gamma-PGA complex. Complex was taken up by dendritic cell line DC2.4 cells efficiently. We subcutaneously administered the complex to mice and examined induction of IgGs. The complex induced not only Th2-type immunoglobulins but also Th1-type immunoglobulins. OVA/BK/gamma-PGA complex inhibited tumor growth of E.G7 cells expressing OVA regularly; administered OVA/BK/gamma-PGA complex completely rejected tumor cells. The novel vaccine could be platform technology for a cancer vaccine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据